Enantioselective synthesis of no-carrier added (NCA) 6-[18F]Fluoro-L-Dopa

被引：0

作者：

Duanzhi Yin

Lan Zhang

Ganghua Tang

Xiaolan Tang

Yongxian Wang

机构：

[1] Chinese Academy of Sciences,Shanghai Institute of Nuclear Research

[2] The First Military Medical University,Nanfang PET Center, Nanfang Hospital

[3] Chinese Academy of Sciences Shanghai Institute of Nuclear Research,Shanghai Institute of Nuclear Research

[4] The First Military Medical University,Nanfang PET Center, Nanfang Hospital

来源：

Journal of Radioanalytical and Nuclear Chemistry | 2003年 / 257卷

关键词：

Dopamine; Radiochemical Purity; Synthesis Route; Triflate; Radiochemical Yield;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

6-[18F]Fluoro-L-Dopa (6-FDOPA) is the analogue of L-Dopa, the biosynthesis precursor for dopamine. As a PET tracer, it was widely applied for the presynaptic dopamine function studies in human brain. The application of a chiral phase-transfer-catalyst (PTC) in enantioselective synthesis of N.C.A. 6-[18F]Fluoro-L-Dopa has been developed recently. An improved procedure was described in this study. The labeling precursor (6-Trimethylammoniumveratraldehyde Triflate) and PTC (O-Allyl-N-(9)-anthracenylcinchonidinium Bromide) were synthesized. A successful synthesis route was developed for the preparation of 6-[18F]Fluoro-L-Dopa with high radiochemical yields (4-9%, decay uncorrected) and short synthesis time(80min). The radiochemical purity was over 99% and no D-isomer was detected by HPLC analysis using a chiral mobile phase.

引用

页码：179 / 185

页数：6

共 50 条

[41] Effect of hypoxia/hypercapnia on metabolism of 6-[18F]fluoro-L-DOPA in newborn piglets
Bauer, R
Brust, P
Walter, B
Vorwieger, G
Bergmann, R
Elhalag, E
Fritz, A
Steinbach, J
Füchtner, F
Hinz, R
Zwiener, U
Johannsen, B
BRAIN RESEARCH, 2002, 934 (01) : 23 - 33
[42] Automated Production of 6-[18F]Fluoro-L-Dopa in a Commercially Available Chemistry Module
Zhang, Z. Y.
Kabalka, G. W.
Longford, C. P. D.
Padgett, H. C.
Journal of Labelled Compounds and Radiopharmaceuticals,
[43] [18F]Fluorination of an arylboronic ester using [18F]selectfluor bis(triflate): application to 6-[18F]fluoro-L-DOPA
Stenhagen, Ida S. R.
Kirjavainen, Anna K.
Forsback, Sarita J.
Jorgensen, Charlotte G.
Robins, Edward G.
Luthra, Sajinder K.
Solin, Olof
Gouverneur, Veronique
CHEMICAL COMMUNICATIONS, 2013, 49 (14) : 1386 - 1388
[44] Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease
Kaasinen, V
Maguire, RP
Hundemer, HP
Leenders, KL
JOURNAL OF NEUROLOGY, 2006, 253 (03) : 340 - 348
[45] Automated synthesis of 6-[18F]fluoro-L-DOPA using modified polystyrene supports with bound 6-mercuric DOPA precursors
Szajek, LP
Channing, MA
Eckelman, WC
APPLIED RADIATION AND ISOTOPES, 1998, 49 (07) : 795 - 804
[46] Automated synthesis of 6-[18F]fluoro-L-DOPA using modified polystyrene supports with bound 6-mercuric DOPA precursors
PET Department, Warren Grant Magnuson Clin. Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, United States
Appl. Radiat. Isot., 7 (795-804):
[47] Blood platelets biokinetics of the neurotransmitter L-Dopamine using 6-[18F]-fluoro-L-Dopa
Leitinger, I.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S622 - S622
[48] Rate of progression in Parkinson's disease:: A 6-[18F]fluoro-L-dopa PET study
Nurmi, E
Ruottinen, HM
Bergman, J
Haaparanta, M
Solin, O
Sonninen, P
Rinne, JO
MOVEMENT DISORDERS, 2001, 16 (04) : 608 - 615
[49] Personality traits and striatal 6-[18F]fluoro-L-dopa uptake in healthy elderly subjects
Kaasinen, V
Nurmi, E
Bergman, J
Solin, O
Kurki, T
Rinne, JO
NEUROSCIENCE LETTERS, 2002, 332 (01) : 61 - 64
[50] A reliable and automated synthesis of 6-[18F]fluoro-L-DOPA and the clinical application on the imaging of congenital hyperinsulinism of infants
Zhang, Zhengwei
Ge, Jingjie
Jing, Kai
Chen, Yefeng
Guan, Yihui
Xie, Hexin
Zhu, Jianhua
MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (07) : 1126 - 1134

← 1 2 3 4 5 →